3 Monster Stocks in the Making

[admin]

Here's why three Motley Fool contributors think Beam Therapeutics (NASDAQ: BEAM), CRISPR Therapeutics (NASDAQ: CRSP), and Sarepta Therapeutics (NASDAQ: SRPT) have what it takes. Keith Speights (Beam Therapeutics): Some technologies simply have the "it factor." Base editing is a type of gene editing.